Compare GMED & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMED | SF |
|---|---|---|
| Founded | 2003 | 1890 |
| Country | United States | United States |
| Employees | N/A | 9000 |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.0B |
| IPO Year | 2012 | N/A |
| Metric | GMED | SF |
|---|---|---|
| Price | $88.16 | $127.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 8 |
| Target Price | $92.42 | ★ $130.00 |
| AVG Volume (30 Days) | ★ 1.4M | 736.2K |
| Earning Date | 02-19-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | ★ 358.86 | 2.14 |
| EPS | 3.08 | ★ 5.66 |
| Revenue | $2,769,804,000.00 | ★ $5,293,276,000.00 |
| Revenue This Year | $16.86 | $13.63 |
| Revenue Next Year | $8.05 | $11.75 |
| P/E Ratio | $28.69 | ★ $22.57 |
| Revenue Growth | 11.75 | ★ 11.76 |
| 52 Week Low | $51.79 | $73.27 |
| 52 Week High | $94.93 | $133.08 |
| Indicator | GMED | SF |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 54.73 |
| Support Level | $87.61 | $127.59 |
| Resistance Level | $89.12 | $129.57 |
| Average True Range (ATR) | 1.67 | 2.47 |
| MACD | -0.61 | -0.33 |
| Stochastic Oscillator | 63.90 | 26.99 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.0 billion in revenue in 2024, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.